Atossa Therapeutics announce support of new breast cancer screening guidelines

Atossa Therapeutics announced its support of new guidelines released by the U.S. Preventive Services Task Force, USPSTF, recommending that women begin breast cancer screening starting at age 40. The updated guidelines recommend women undergo biennial mammography screening beginning at the age of 40 until the age of 74. “The new guidelines will undoubtedly improve timely access to patient care and save lives by enabling earlier diagnosis and treatment of breast cancer,” said Steven Quay, M.D., Ph.D., Atossa’s President and Chief Executive Officer. “However, a bigger opportunity to help women is by developing therapies to prevent breast cancer from ever occurring. Half the women in the world over the age of 40 have dense breast tissue and women with very dense breasts are five-times more likely to get breast cancer than women with fatty breasts.”